B. Milleron

发表

Management strategy of pulmonary nodule in 2013.

F. Laurent, M. Lederlin, M. Revel, 2013, Diagnostic and interventional imaging.

Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors.

B. Milleron, I. Debrix, C. Bouleuc, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer in never smokers--a review.

Sébastien Couraud, Franck Morin, Gérard Zalcman, 2012, European journal of cancer.

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Jean Mosser, Franck Morin, Gérard Zalcman, 2016, The Lancet.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Hanna El Balaa, Jean-Noël Talbot, E. Touboul, 2005, International journal of radiation oncology, biology, physics.

Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancer.

B. Milleron, M. Wislez, A. Khalil, 2007, Lung cancer.

Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.

B. Milleron, T. Soussi, R. Lubin, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic significance of serum p53 antibodies in patients with limited‐stage small cell lung cancer

B. Milleron, T. Soussi, V. Meignin, 2000, International journal of cancer.

Silica‐associated Connective Tissue Disease: A Study of 24 Cases

B. Milleron, J. Arnaud, S. Rozenberg, 1995, Medicine.

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

E. Touboul, T. Molina, E. Lemarié, 2003, British Journal of Cancer.

Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study.

E. Lemarié, B. Milleron, E. Quoix, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of guidelines implemented in a paris university hospital: application to the use of antiemetics by cancer patients.

A. Flahault, B. Milleron, I. Debrix, 2001, British Journal of Clinical Pharmacology.

A prospective study of detorubicin in malignant mesothelioma

B. Milleron, M. Schlienger, J. Vannetzel, 1985, Cancer.

Maintenance with either gemcitabine or erlotinib versus observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy in advanced NSCLC: IFCT-GFPC 0502 phase III study.

B. Milleron, F. Barlesi, C. Chouaid, 2010 .

Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF‐β and IL-10

B. Milleron, D. Valeyre, P. Soler, 2003, European Respiratory Journal.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Antoine Flahault, Catherine Beigelman-Aubry, Yves Martinet, 2007, Lung cancer.

Hepatocyte Growth Factor Production by Neutrophils Infiltrating Bronchioloalveolar Subtype Pulmonary Adenocarcinoma : Role in Tumor Progression and Death 1

B. Milleron, B. Crestani, M. Antoine, 2003 .

Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.

E. Lemarié, B. Milleron, J. Daurès, 2001, Journal of the National Cancer Institute.

Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells

B. Milleron, M. Antoine, M. Wislez, 2003, Inflammation Research.

Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.

B. Milleron, M. Antoine, M. Wislez, 2001, The American journal of pathology.

Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française.

J. Lafitte, B. Milleron, E. Brambilla, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Standards, Options et Recommandations pour la prise en charge des patients atteints d'un cancer bronchique primitif de stade I ou II traités par irradiation exclusive.

E. Touboul, B. Milleron, J. Lagrange, 2001 .

French phase III trial of preoperative chemotherapy (PCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC)

E. Lemarié, B. Milleron, S. Chevret, 2000 .

B. Milleron, O. Molinier, D. Moro-Sibilot, 2015, Journal of geriatric oncology.

[Bronchial cancer in patients infected with human immunodeficiency virus (HIV). Report of 3 cases].

B. Milleron, J. Cadranel, J. Igual, 1990, Revue de pneumologie clinique.

quels patients âgés ? Cancers bronchopulmonaires non à petites cellules Non-small-cell lung cancer

B. Milleron, M. Wislez, L. Belmont, 2008 .

Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.

A. Flahault, B. Milleron, J. Bernaudin, 1998, The American journal of pathology.

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.

B. Milleron, D. Spaeth, J. Pujol, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival

B. Milleron, S. Lantuejoul, G. Zalcman, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Skin Toxicities Compromise Prolonged Pemetrexed Treatment

B. Milleron, M. Wislez, V. Gounant, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

IFCT0401 trial: Phase II study of gefitinib administered as first-line treatment in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC): Final results on efficacy and survival

B. Milleron, J. Soria, D. Moro-Sibilot, 2007 .

Patient participation in thoracic cancer clinical trials.

B. Milleron, J. Pujol, M. Chakra, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Management and outcome of French elderly patients with lung cancer: an IFCT survey].

B. Milleron, P. Souquet, P. Girard, 2010, Revue des maladies respiratoires.

Diagnosis of smear-negative pulmonary tuberculosis using sequence capture polymerase chain reaction.

B. Milleron, A. Hance, O. Brugière, 1997, American journal of respiratory and critical care medicine.

Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients

B. Milleron, L. Baud, B. Fouqueray, 1993, Clinical and experimental immunology.

Impact of randomized clinical trials on clinical practice regarding treatment of lung cancer.

B. Milleron, M. Wislez, I. Debrix, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)

E. Quoix, B. Mennecier, G. R. Ferretti, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

B. Milleron, O. Molinier, G. Zalcman, 2016, European Respiratory Journal.

In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients

B. Milleron, R. Ardaillou, L. Baud, 1990, Clinical and experimental immunology.

Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies.

B. Milleron, C. Mayaud, G. Akoun, 1985, British medical journal.

1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis.

B. Milleron, A. Hance, J. Cadranel, 1990, The Journal of clinical investigation.

Availability of results of academic randomized trials involving cooperative groups in oncology in France: a systematic search of clinical trial registries.

B. Milleron, P. Créquit, A. Vivot, 2022, Journal of cancer policy.

Severe hypoxemia-associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment.

B. Milleron, S. Adnot, J. Brouet, 1992, The American review of respiratory disease.

Pleural T-lymphocyte subsets in amiodarone-associated pleuropneumonitis.

B. Milleron, C. Mayaud, G. Akoun, 1989, Chest.

Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer.

E. Lemarié, B. Milleron, D. Moro-Sibilot, 2010 .

An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.

B. Milleron, C. Chastang, D. Moro, 1994, Seminars in oncology.

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.

N. Girard, E. Devin, J. Muir, 2022, The Lancet. Oncology.

[DEPISCAN--a pilot study to evaluate low dose spiral CT scanning as a screening method for bronchial carcinoma].

A. Flahault, E. Lemarié, B. Milleron, 2002, Revue des maladies respiratoires.

Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.

B. Milleron, D. Moro-Sibilot, E. Quoix, 2005, Chest.

O-211 5-year results of the French randomized study comparing preoperative chemotherapy followed by surgery and primary surgery in resectable stage I (except T1N0), II and IIIA non-small cell lung cancer

E. Lemarié, B. Milleron, D. Moro-Sibilot, 2003 .

Expression of 1,25(OH)2D3 receptors on alveolar lymphocytes from patients with pulmonary granulomatous diseases.

B. Milleron, D. Valeyre, P. Soler, 1991, The American review of respiratory disease.

Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease.

B. Milleron, M. Denis, J. Perrot, 1987, Thorax.

In Reply: Bronchoalveolar T-cell Subsets in Gold Lung

B. Milleron, J. Perrot, C. Mayaud, 1985 .

Provocation test coupled with bronchoalveolar lavage in diagnosis of propranolol-induced hypersensitivity pneumonitis.

B. Milleron, C. Mayaud, G. Akoun, 1989, The American review of respiratory disease.

Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis

B. Milleron, A. Roche, J. Cadranel, 1990 .

Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis. Association with angioimmunoblastic lymphadenopathy and severe hypoxemia.

B. Milleron, A. Roche, J. Cadranel, 1990, Gastroenterology.

Bevacizumab 15mg/kg plus cisplatin-pemetrexed (CP) triplet versus CP doublet in Malignant Pleural Mesothelioma (MPM): Results of the IFCT-GFPC-0701 MAPS randomized phase 3 trial.

B. Milleron, J. Mazières, G. Zalcman, 2015 .

Concurrent chemoradiation for elderly patients with locally advanced non-small-cell lung cancer: still a controversial issue

B. Milleron, E. Quoix, V. Westeel, 2012 .

Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue française.

B. Milleron, E. Brambilla, D. Moro, 1994, Anticancer research.

Primary pulmonary lymphoma

B. Milleron, J. Bernaudin, M. Antoine, 2002, European Respiratory Journal.

Multimodal treatment of thymic carcinoma: Report of nine cases.

B. Milleron, P. Blancard, E. Magois, 2008, Lung cancer.

Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis.

B. Milleron, A. Hance, J. Cadranel, 1988, The American review of respiratory disease.

Serum concentrations of vitamin D metabolites in untreated tuberculosis.

B. Milleron, J. Cadranel, M. Garabédian, 1985, Thorax.

Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients.

B. Milleron, J. Cadranel, C. Mayaud, 1991, Chest.

Leukocyte migration inhibition in amiodarone-associated pneumonitis.

B. Milleron, C. Mayaud, G. Akoun, 1988, Chest.

Amiodarone pulmonary toxicity.

B. Milleron, C. Mayaud, G. Akoun, 1986, Chest.

Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism.

B. Milleron, J. Perrot, C. Mayaud, 1984, Chest.

Association d’un lymphome thymique de type MALT et d’un syndrome de Gougerot-Sjögren

C. Copie-Bergman, B. Milleron, M. Antoine, 2009 .

[Association between thymic MALT lymphoma and Sjögren's syndrome].

C. Copie-Bergman, B. Milleron, M. Antoine, 2009, Revue de pneumologie clinique.

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

B. Milleron, S. Laporte, J. Trédaniel, 2007, Revue des maladies respiratoires.

[Emergency treatment of severe hemoptysis by embolization of systemic arteries].

B. Milleron, M. Carette, J. Bigot, 1983, Presse medicale.

Lung cancer in HIV infected patients: facts, questions and challenges

B. Milleron, M. Wislez, D. Garfield, 2006, Thorax.

Lung cancer, a new challenge in the HIV-infected population.

B. Milleron, M. Antoine, M. Wislez, 2006, Lung cancer.

B. Milleron, M. Wislez, D. Garfield, 2006 .

[Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].

B. Milleron, B. Dupont, P. Roux, 1990, Revue de pneumologie clinique.

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

B. Milleron, O. Molinier, S. Laporte, 2011, The Lancet.

Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.

B. Milleron, H. Scarna, D. Herman, 1985, Chest.

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Olivier Molinier, Franck Morin, Christian Creveuil, 2016, The Lancet.

Clinical characteristics of pneumonic-type adenocarcinoma of the lung.

B. Milleron, M. Antoine, M. Wislez, 2003, Chest.

CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure.

P. Beaune, D. Hémon, B. Milleron, 1995, Carcinogenesis.

The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.

B. Milleron, J. Fontan, I. Debrix, 2001, Clinical therapeutics.

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

J. Pignon, B. Milleron, J. Soria, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

MDR1-Pgp 170 expression in human bronchus.

B. Milleron, J. Bernaudin, I. Hurbain, 1997, The European respiratory journal.

Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy.

B. Milleron, M. Antoine, M. Wislez, 2013, Lung cancer.

IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype

B. Milleron, J. Soria, D. Moro-Sibilot, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning.

J C Rosenwald, P Giraud, E. Touboul, 2000, International journal of radiation oncology, biology, physics.

Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer.

B. Milleron, M. Taron, G. Zalcman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80).

B. Milleron, P. Berna, E. Hoguet, 2021, Clinical lung cancer.

Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.

B. Chauffert, B. Milleron, P. Berna, 2019, Clinical lung cancer.

Current knowledge on perioperative treatments of non-small cell lung carcinomas

Y. Castier, B. Milleron, P. Mordant, 2017 .

Lung cancer screening: what is new since the NLST results?

Sébastien Couraud, B. Milleron, S. Couraud, 2016, Current Pulmonology Reports.

An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial

P. Hainaut, B. Milleron, E. Brambilla, 2012, Clinical Cancer Research.

Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.

B. Milleron, B. Crestani, M. Antoine, 2003, Cancer research.

Leukocyte Migration Inhibition in Propranolol-induced Pneumonitis

B. Milleron, C. Mayaud, G. Akoun, 1990 .

B. Milleron, J. Perrot, C. Mayaud, 1984, The Lancet.

Factors associated with long‐term survival of patients with advanced non‐small cell lung cancer

B. Milleron, M. Wislez, V. Gounant, 2012, Respirology.

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial.

E. Lemarié, B. Milleron, C. Chastang, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[Non-small cell lung carcinoma: Perspectives for the twenty-first century?].

B. Milleron, 2011, Presse medicale.

Weekly Paclitaxel Combined with Monthly Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

B. Milleron, O. Molinier, J. Pujol, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Preoperative C hemotherapy F ollowed b y S urgery C ompared With P rimary S urgery i n R esectable S tage I ( Except T1N0), I I, a nd I IIa N on-Small-Cell L ung C ancer

E. Lemarié, B. Milleron, L. Thiberville, 2002 .

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

E. Lemarié, B. Milleron, L. Thiberville, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bronchogenic cyst presenting as mediastinal mass with pleural effusion.

B. Milleron, A. Khalil, M. Carette, 1995, The European respiratory journal.

[Isolated cystic lymphangioma in the mediastinum].

B. Milleron, F. Blanchon, G. Akoun, 1978, Le Poumon et le coeur.

Sarcoidosis associated with leucocytoclastic vasculitis. A case report and review of the literature.

B. Milleron, L. Dubertret, S. Aractingi, 1993, Dermatology.

Adult-onset Still's disease revealed by a pleuropericarditis.

B. Milleron, F. Lioté, D. Kuntz, 1990, The European respiratory journal.

Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS‐CO4 French Hospital Database on HIV cohort

B. Milleron, F. Lert, M. Guiguet, 2019, HIV medicine.

Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group

B. Milleron, J. Pujol, J. Spano, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.

B. Milleron, M. Wislez, G. Pialoux, 2009, Lung cancer.

Light chain deposition disease involving the airways: diagnosis by fibreoptic bronchoscopy

B. Milleron, H. Mal, V. Gounant, 2007, European Respiratory Journal.

[Immunological studies in hypersensitivity pneumopathies].

B. Milleron, J. Cadranel, C. Mayaud, 1988, Revue des maladies respiratoires.

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial).

E. Lemarié, B. Milleron, O. Molinier, 2013, European journal of cancer.

Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic.

B. Milleron, V. Gounant, J. Cadranel, 2012, Bulletin du cancer.

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

N. Girard, B. Milleron, J. Douillard, 2010, Lung cancer.

Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

J. Pignon, B. Milleron, D. de Ruysscher, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Current aspects of spinal tuberculosis. Apropos of 10 cases].

B. Milleron, J. Cadranel, C. Le Breton, 1996, Revue de pneumologie clinique.

Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized Trials

B. Milleron, O. Molinier, G. Zalcman, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.

B. Milleron, J. Trédaniel, G. Zalcman, 2016, European journal of cancer.

Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone)

B. Milleron, M. d’Ortho, J. Cadranel, 1991, Chest.

Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations.

B. Milleron, M. Antoine, M. Wislez, 1999, The European respiratory journal.

Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.

B. Milleron, L. Israël, A. Depierre, 1977, Cancer treatment reports.

Imaging findings in three cases of the nodular type of muscular sarcoidosis.

B. Milleron, A. Sobotka, A. Khalil, 2004, AJR. American journal of roentgenology.

Original Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study

E. Lemarié, B. Milleron, L. Moreau, 2005 .

Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations.

B. Milleron, D. Valeyre, A. Hance, 1994, The European respiratory journal.

Vitamin D D m metabolism bby aalveolar iimmune ccells in ttuberculosis: ccorrelation w with ccalcium m metabolism and cclinical m manifestations

B. Milleron, D. Valeyre, M. Garabédian, 1994 .

B. Milleron, C. Mayaud, J. Valcke, 1996 .

B. Milleron, C. Mayaud, J. Valcke, 1996, Chest.

2014 update on non-small cell lung cancer (excluding diagnosis).

B. Milleron, M. Antoine, M. Wislez, 2014, Diagnostic and interventional imaging.

Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

E. Lemarié, B. Milleron, D. Spaeth, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study

J. Lafitte, B. Milleron, E. Brambilla, 1997 .

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer

B. Milleron, O. Molinier, J. Trédaniel, 2013, European Respiratory Journal.

Chemotherapy in elderly patients with advanced non-small cell lung cancer.

B. Milleron, G. Zalcman, E. Quoix, 2011, Lung cancer.

GSTM1, smoking and lung cancer: a case-control study.

P. Beaune, D. Hémon, B. Milleron, 1999, International journal of epidemiology.

Prise en charge thérapeutique des adénocarcinomes de type bronchiolo-alvéolaires étendus : chimiothérapie ou inhibiteurs de la tyrosine kinase du récepteur de l'epidermal growth factor ?

B. Milleron, M. Antoine, M. Wislez, 2007 .

Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence.

B. Milleron, M. Riquet, J. Bernaudin, 2005, European journal of cancer.

Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?

K. Rosenzweig, P. Giraud, B. Milleron, 2006, International journal of radiation oncology, biology, physics.

[Should the extended evaluation of bronchial adenocarcinoma be different from that of non-small cell lung carcinoma?].

B. Milleron, L. Rosencher, J. Guigay, 1992, Revue de pneumologie clinique.

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

B. Milleron, F. Le Pimpec Barthès, O. Molinier, 2022, Journal for ImmunoTherapy of Cancer.

[An uncommon germ of meningitis, Achromobacter xylosoxidans].

B. Milleron, A. Guillard, J. Ferroir, 1991, Presse medicale.

1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)

B. Milleron, O. Molinier, J. Mazières, 2020 .

1151MO Pathological response is an independent factor of overall survival and disease-free survival after neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase II trial

B. Milleron, F. Le Pimpec Barthès, J. Mazières, 2021, Annals of Oncology.

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

B. Milleron, G. Zalcman, D. Moro-Sibilot, 2018, Revue des maladies respiratoires.

Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.

B. Milleron, D. Moro-Sibilot, E. Quoix, 2005, Journal of the National Cancer Institute.

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

B. Milleron, E. Quoix, A. Depierre, 2006, Lung cancer.

[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].

B. Milleron, B. Housset, J. Talbot, 2010, Revue de pneumologie clinique.

Bronchoalveolar lavage cell data in drug-induced pneumonitis.

E. Rosenow, B. Milleron, J. Cadranel, 1991, Allergie et immunologie.

Bronchoalveolar lavage cell data in alveolar proteinosis.

B. Milleron, U. Costabel, H. Matthys, 1991, The American review of respiratory disease.

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study).

B. Milleron, G. Zalcman, D. Moro-Sibilot, 2010, Lung cancer.

Intergroupe francophone de cancérologie thoracique, Société de pneumologie de langue française, and Société d'imagerie thoracique statement paper on lung cancer screening.

N. Girard, F. Laurent, M. Revel, 2021, Diagnostic and interventional imaging.

Computed tomographic diagnosis of bronchogenic carcinoma in HIV-infected patients.

B. Milleron, M. Bazot, M. Carette, 2000, Lung cancer.

Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer. No significant change of staging.

B. Milleron, M. Carette, J. Cadranel, 1994, Chest.

Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations

P. Grenier, F. Laurent, B. Milleron, 2017, BMC Public Health.

Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC).

E Pichon, B. Milleron, G. Zalcman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse panbronchiolitis in an Asian immigrant.

B. Milleron, M. Antoine, O. Brugière, 1996, Thorax.

[The treatment of tracheobronchial amyloidosis using a bronchial laser. Apropos of a series of 13 cases].

B. Milleron, C. Personne, D. Herman, 1985, Revue des maladies respiratoires.

[Lung cancer in never smokers: a French national cohort (BioCAST/IFCT-1002)].

H. Blanché, B. Milleron, G. Zalcman, 2013, Revue des maladies respiratoires.

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer.

E. Lemarié, B. Milleron, A. Monnier, 2000, European journal of cancer.

Rapid and Sensitive p53 Alteration Analysis in Biopsies from Lung Cancer Patients Using a Functional Assay and A Universal Oligonucleotide Array

F. Barany, B. Milleron, T. Soussi, 2004, Clinical Cancer Research.

[Intramedullary metastases of bronchogenic carcinoma. Two cases].

B. Milleron, S. Contant, A. Khalil, 1998, Revue neurologique.

[Anticancer chemotherapy in the elderly: a review of the literature].

B. Milleron, J. Gligorov, J. Lotz, 2008, Bulletin du Cancer.

[Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients].

E. Touboul, T. Molina, E. Lemarié, 2003, Bulletin du cancer.

[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].

E. Touboul, E. Lemarié, B. Milleron, 2001, Bulletin du cancer.

Thyroid tuberculosis associated with mediastinal lymphadenitis.

B. Milleron, B. Bazelly, G. Akoun, 1987, Tubercle.

Pleural, alveolar and blood T-lymphocyte subsets in pleuropulmonary sarcoidosis.

B. Milleron, J. Cadranel, G. Akoun, 1990, Chest.

[Efficacy of the granisetron/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey].

B. Milleron, I. Debrix, A. Becker, 1995, Annales Pharmaceutiques Françaises.

Delays in the diagnosis and treatment of lung cancer.

B. Milleron, L. Rosencher, G. Mangiapan, 1997, Thorax.

Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized Trials

B. Milleron, O. Molinier, G. Zalcman, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Drug-induced pneumopathies accompanied by acute respiratory insufficiency].

B. Milleron, J. Cadranel, G. Mangiapan, 1996, Revue des maladies respiratoires.

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer.

E. Lemarié, B. Milleron, J. Pujol, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

IFCT0002 phase III study comparing a preoperative (PRE) and a perioperative (PERI) chemotherapy with two different CT regimens in resectable non-small cell lung cancer (NSCLC): Early results

B. Milleron, J. Pujol, E. Quoix, 2007 .

Results of the IFCT 0002 phase III study comparing a preoperative and a perioperative chemotherapy (CT) with two different CT regimens in resectable non-small cell lung cancer (NSCLC).

B. Milleron, J. Pujol, E. Quoix, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of Ras effector RASSF1A promoter gene methylation and chromosome 9p loss of heterozygosity (LOH) to predict progression-free survival (PFS) in perioperative chemotherapy (CT) phase III trial IFCT-0002 in resectable non-small cell lung cancer

B. Milleron, G. Zalcman, E. Bergot, 2008 .

[Endobronchial metastases of cancer. Apropos of 29 cases].

B. Milleron, P. Fouret, G. Akoun, 1986, Revue de Pneumologie Clinique.

Pazopanib (P) or placebo in completely resected stage I NSCLC patients: Survival results of the phase II trial IFCT-0703.

J. Pignon, B. Milleron, J. Soria, 2015 .

Perception of Lung Cancer among the General Population and Comparison with Other Cancers

B. Milleron, J. Mazières, J. Pujol, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

CT lung cancer screening: where are we heading to?

B. Milleron, E. Quoix, B. Mennecier, 2014 .

Phase III randomized study of Neo-Adjuvant chemotherapy surgery in non-small cell lung cancer (NSCLC) preliminary results

E. Lemarié, B. Milleron, C. Chastang, 1994 .

[Script concordance test for knowledge assessment of lung cancer screening].

B. Milleron, B. Charlin, P. Girard, 2016, Revue des maladies respiratoires.

Serum Neuron-Specific Enolase Levels in Lung Diseases: a Valuable Marker for Small-Cell Lung Cancer

B. Milleron, H. Scarna, G. Akoun, 1985 .

Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.

B. Milleron, M. Antoine, M. Carette, 2011, Lung cancer.

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

B. Milleron, O. Molinier, J. Mazières, 2016, The Lancet.

[Recommendations of French specialists on screening for lung cancer].

N. Girard, F. Laurent, M. Revel, 2021, Revue des maladies respiratoires.